Planning Recruitment When the Enrollment Window Won't Move
Seasonal and window-limited studies punish steady pacing. Here's how to work backward from the cutoff date, front-load outreach, and staff for a six-week surge instead of an average month.
By Trialflow Team
Flu vaccine trials, RSV studies, seasonal allergy protocols, and any study with a hard enrollment cutoff all share one problem: the window doesn't move. If you miss it, you don't recover — you wait a year. Planning for these studies looks different from planning for a chronic-disease protocol you can enroll into for eighteen months.
Work backward from the last possible randomization date
Start with the date the sponsor stops accepting randomizations, then subtract everything that has to happen before it. For a study requiring a screening visit, a lab turnaround, and an eligibility review before dosing, your real last-contact date may be three or four weeks earlier than the stated cutoff. Write that date on the wall.
Then subtract your typical pre-screen-to-consent lag. In most site datasets that gap is a week or more once you account for callbacks, scheduling, and no-shows. Your practical outreach deadline is often a full month ahead of the official close.
Front-load, don't pace
For open-ended studies, steady weekly enrollment is healthy. For seasonal studies it's a failure mode. Circulating respiratory virus, pollen counts, and sponsor-level enrollment caps all mean early slots are worth more than late ones. Competing sites fill the global cap and your last three consented patients get turned away.
Practical consequences:
- Build your pre-screen pool before site activation, not after. Regulatory approval timelines slip; your outreach planning shouldn't.
- Schedule screening visits in blocks rather than one at a time. Four patients on a Tuesday morning uses coordinator time far better than four spread across a week.
- Plan for overbooking. If your no-show rate on first visits is meaningful, book above capacity on purpose and have a contingency for the rare day everyone shows.
Pre-build everything that can be pre-built
The ads, the phone script, the pre-screening questionnaire, the consent appointment template, the staffing plan — all of it should exist in draft before the study opens. Submitting recruitment materials to the IRB alongside the protocol rather than after activation can save weeks you simply don't have.
Keep a reusable seasonal kit: last year's approved ad copy with the dates and protocol numbers stripped out, the pre-screen question set, the lab courier schedule, the vendor contacts. Rebuilding this each September is wasted effort.
Staff for the peak, not the average
Seasonal studies produce concentrated workload. Six weeks of near-capacity screening, then nothing. Decide early who covers phones during the surge, whether you need weekend or evening visit slots, and who handles data entry so queries don't pile into January. Borrowing a coordinator from a slower study for a defined six-week stretch is usually cheaper than losing half your target.
Monitor daily, not weekly
When the window is eight weeks long, a weekly enrollment review gives you seven chances to course-correct. Track pre-screens, consents, and randomizations daily during the peak. If outreach channel response drops off, you want to know within forty-eight hours, not at the next team meeting.
Decide your stop rule in advance
Agree with your PI early on what triggers pulling back: a date, a randomization count, or a point where remaining slots can't realistically be filled. Spending ad budget in the final week on patients who can't complete screening before cutoff helps nobody. A clean, early decision to stop is better than a scramble that produces screen failures and frustrated candidates you'd rather keep for next season.
Enrolling studies shouldn't be this hard
Trialflow gives research sites one platform for lead management, AI trial matching, and recruitment analytics.
Request a Demo